Physician profile
Michael B Phillips
NPI 1386087088
$753.15
in general payments reported to CMS, 2019-2025
12 companies · $9.21 in 2025
The $9.21 reported for 2025 was less than what a typical Acute Care (Clinical Nurse Specialist) provider received nationally (typical 2025 total: $137).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $147 · 2022: $142 · 2023: $174 · 2024: $281 · 2025: $9.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $464.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elutia, INC. | $181.28 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $159.90 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $124.99 | 2021 | |
| Ardelyx, INC. | $121.19 | 2024 | Xphozah 30 Mg |
| Mallinckrodt Hospital Products INC. | $29.60 | 2024 | Terlivaz |
| Amgen INC. | $28.88 | 2024 | Krystexxa |
| Vifor Pharma, INC. | $25.23 | 2024 | Veltassa |
| Daiichi Sankyo INC. | $21.59 | 2021 | |
| Calliditas Therapeutics US INC. | $17.98 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $16.99 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $16.31 | 2024 | Jynarque |
| Phathom Pharmaceuticals, INC. | $9.21 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.